Informations for option: Tolterodine Tartrate 1 Mg Film-Coated Tablet, show other option

Select option:

1. Tolterodine Tartrate 1 Mg Film-Coated Tablet
2. Tolterodine Tartrate 1 Mg Film-Coated Tablet

PACKAGE LEAFLET: INFORMATION FOR THE USER

Tolterodine Tartrate 1 mg Film-coated Tablet Tolterodine Tartrate 2 mg Film-coated Tablet

Tolterodine tartrate

Read all of this leaflet carefully before you start using this medicine. because it contains important information for you.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist

•    This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet (See section 4)

What is in this leaflet:

1.    What Tolterodine Tartrate is and what it is used for

2.    What you need to know before you take Tolterodine Tartrate

3.    How to take Tolterodine Tartrate

4.    Possible side effects

5.    How to store Tolterodine Tartrate

6.    Contents of pack and other information

1. WHAT TOLTERODINE

TARTRATE IS AND WHAT IT IS USED FOR

The active substance is tolterodine. Tolterodine belongs to a class of medicinal products called antimuscarinics.

Tolterodine is used for the treatment of the symptoms of overactive bladder syndrome. If you have overactive bladder syndrome, you may find that you are unable to control urination that you need to rush to the toilet with no advance warning and/or go to the toilet frequently.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TOLTERODINE TARTRATE

Do not take Tolterodine Tartrate

•    If you are allergic (hypersensitive) to tolterodine or any of the other ingredients in the medicine

•    If you are unable to pass urine from the bladder (urinary retention)

•    If you have uncontrolled narrow angle glaucoma (increase in intraocular pressure)

•    If you suffer from myasthenia gravis (excessive weakness of the muscles)

•    If you suffer from severe ulcerative colitis (ulceration and inflammation of the colon)

•    If you suffer from a toxic megacolon (acute dilatation of the colon).

Warning and precautions

•    If you have difficulties in passing urine and/or a poor stream of urine

•    If you have a gastro-intestinal disease that affects the passage and/or digestion of food

•    If you suffer from kidney problems (renal insufficiency)

•    If you have a liver condition

•    If you suffer from neuronal disorders that affect your blood pressure, bowel or sexual function (any neuropathy of the autonomic nervous system)

•    If you have a hiatal hernia (herniation of an abdominal organ)

•    If you ever experience decreased bowel movements or suffer from severe constipation (decreased gastro-intestinal motility)

•    If you have a heart condition such as:

-    an abnormal heart tracing (ECG);

-    a slow heart rate (bradycardia);

-    relevant pre-existing cardiac diseases (cardiomyopathy (weak heart muscle), myocardial ischaemia (reduced blood flow to the heart), arrhythmia (irregular heartbeat) and heart failure)

•    If you have abnormally low levels of potassium (hypokalaemia), calcium hypocalcaemia) or magnesium (hypomagnesaemia) in your blood

•    If you are taking any medicine for the treatment of an irregular heartbeat (arrhythmia) (see 'taking other medicines').

Ask your doctor or pharmacist before starting this treatment if you think any of these might apply to you.

Other medicines and Tolterodine Tartrate

Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Tolterodine, the active substance of tolterodine, may interact with other medicinal products.

It is not recommended to use tolterodine in

combination with

•    some antibiotics (containing e.g. erythromycin, clarithromycin);

•    medicinal products used for the treatment of fungal infections (containing e.g. ketoconazole, itraconazole);

•    medicinal products used for the treatment of HIV

Tolterodine should be used with caution when

taken in combination with

•    medicines that affect the passage of food (containing e. g. Metoclopramide, domperidone and cisapride)

•    medicines for the treatment of irregular heartbeat (containing e.g. amiodarone, sotalol, quinidine, procainamide) (see 'Take special care with tolterodine')

•    other medicinal products with antimuscarinic (medicines with a similar mode of action to tolterodine such as amantadine, some antihistamines, phenothiazine antipsychotics and tricyclic antidepressants) or cholinergic (medicines with an opposite mode of action to tolterodine) properties. The reduction in gastric motility caused by antimuscarinics may affect the absorption of other drugs.

Tolterodine Tartrate with food and drink

This medicine can be taken before, after or during a meal.

Pregnancy, breast-feeding and fertility

Pregnancy

You should not use tolterodine when you are pregnant. Tell your doctor immediately if you are pregnant, think you are pregnant or are planning to become pregnant.

Breast-feeding

It is not known if tolterodine is excreted in the mother's breast milk. Breast-feeding is not recommended during administration of tolterodine.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Tolterodine may make you feel dizzy, tired or affect your sight; your ability to drive or operate machinery may be affected.

3. HOW TO TAKE TOLTERODINE TARTRATE

Dosage

Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The usual dose is one 2 mg tablet twice daily, except for patients who have a kidney or a liver condition or troublesome side effects in which case your doctor may reduce your dose to one 1 mg tablet twice daily.

Tolterodine Tartrate is not recommended for children.

The tablets are for oral use and should be swallowed whole.

Duration of treatment

Your doctor will tell you how long your treatment with Tolterodine Tartrate will last. Do not stop treatment early because you do not see an immediate effect. Your bladder will need some time to adapt. Finish the course of tablets prescribed by your doctor. If you have not noticed any effect by then, talk to your doctor.

The benefit of the treatment should be re-evaluated after 2 or 3 months.

Always consult your doctor if you are thinking of stopping the treatment.

If you have taken more Tolterodine Tartrate than you should:

If you or somebody else takes too many tablets, contact your doctor or pharmacist at immediately.

In case of tolterodine overdose, the following symptoms are reported.

•    Severe central anticholinergic effects (e.g. hallucinations, severe excitation)

•    Convulsions or pronounced excitation

•    Respiratory insufficiency

•    Tachycardia

•    Urinary retention

•    Mydriasis

•    Increase in QT interval

If you forget to take Tolterodine Tartrate

Do not take a double dose to make up for a forgotten one. If you have forgotten to take a dose at the usual time, you can take it as soon as you remember unless it is almost time for your next dose. In that case follow the normal dose schedule.

If you stop using Tolterodine Tartrate

If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, tolterodine can cause side effects, although not everybody gets them.

You should see your doctor immediately or go to the casualty department if you experience symptoms of angioedema, such as

•    swollen face, tongue or pharynx

•    difficulty to swallow

•    hives and difficulty in breathing

You should also seek medical attention if you experience a hypersensitivity reaction (for example itching, rash, hives, difficulty breathing). This occurs uncommonly (occurs in less than 1 in 100 patients).

Tell your doctor immediately or go to the casualty department if you notice any of the following:

•    chest pain, difficulty breathing or getting tired easily (even at rest), difficulty breathing at night, swelling of the legs.

These may be symptoms of heart failure. This occurs uncommonly (occurs in less than 1 in 100 patients).

The following side effects have been observed during treatment with tolterodine with the following frequencies.

Very common (occurs in more than 1 in 10 patients) side effects are:

•    Dry mouth

•    Headache

Common (occur in less than 1 per 10 patients) side effects are:

•    Bronchitis

•    Dizziness

•    Sleepiness

•    Dry eyes

•    Blurred vision

•    Abdominal pain

•    Spinning sensation

•    Palpitations

•    Dry skin

•    Bad digestion (dyspepsia)

•    Constipation

•    Tiredness

•    Painful or difficult urination

•    Increased weight

•    Chest pain

•    Being sick (vomiting)

•    Inability to empty the bladder

•    Diarrhoea

•    Sensation of pins and needles in the fingers and toes

•    Excessive amounts of air or gases in the stomach or the intestine

•    Extra fluid in the body causing swelling (e.g. in the ankles)

Uncommon (occur in less than 1 per 100 patients) side effects are:

•    Allergic reactions

•    Nervousness

•    Irregular heartbeat

•    Increased heart rate

•    Heart failure

•    Heart burn

•    Memorial impairment

This medicinal product is authorised in the Member States of the EEA under the following names:

Proposed Name Tolterodintartrat Accord 1 mg / 2 mg filmovertrukne tabletter

Tolterodine Accord 2 mg Film-coated Tablets Tolterodine Accord 2 mg Film-coated Tablets Tolterodine Accord 1 mg / 2 mg Tolterodine Accord 1 mg / 2 mg Film-coated Tablets Ranolteril, 1 mg/ 2 mg, tabletki powlekane

Tolterodin Accord 1 mg/2 mg Filmtabletten

Tolterodin Accord 1 mg/2 mg Filmtabletten

Tolterodine Accord 1 mg/ 2 mg comprime pellicule Tolterodine Tartrate 1 mg/2 mg Film-coated Tablet Tolterodinetartraat Accord 1 mg/2 mg filmomhulde tabletten

Tolterodintartrat Accord 1 mg / 2 mg filmdragerade tabletter

Tolterodine Tartrate 1 mg/2 mg Film-coated Tablet

This leaflet was last revised in 10/2015.

Additional reactions reported from post marketing experience include severe allergic reactions, confusion, hallucinations (seeing, hearing, feeling, tasting or smelling things that are not there), flushing, angioedema and disorientation. There have also been reports of worsening symptoms of dementia in patients being treated for dementia.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.

For UK - You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard

For IE- You can also report side effects directly HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

5. HOW TO STORE

TOLTERODINE TARTRATE

Keep this medicine out of the sight and reach of children.

Do not use tolterodine film-coated tablets after the expiry date, which is stated on the label/carton. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

6. CONTENTS OF PACK AND OTHER INFORMATION

What Tolterodine Tartrate contains

The active substance is 1 mg of tolterodine tartrate, equivalent to 0.68 mg of tolterodine.

The active substance is 2 mg of tolterodine tartrate, equivalent to 1.37 mg of tolterodine.

The other ingredients are:

Core: Cellulose, microcrystalline; sodium starch glycolate (Type A); magnesium stearate; colloidal anhydrous silica

Film coating: Hypromellose (E464), titanium dioxide (E171), macrogol 8000, talc (E553b)

What Tolterodine Tartrate looks like and contents of the pack

Tolterodine Tartrate 1 mg film-coated tablets are white to off white, round, approximately 6.35 mm in diameter, biconvex, film-coated tablet, debossed S16 on one side and plain on other side.

Tolterodine Tartrate 2 mg film-coated tablets are white to off white, round, approximately 6.35 mm in diameter, biconvex, film-coated tablet, debossed S042 on one side and plain on other side.

Tolterodine Tartrate 1 mg film-coated tablets are available in the following pack sizes:

Tolterodine Tartrate 2 mg film-coated tablets are available in the following pack sizes:

Blister packs containing;

•    14 film-coated tablets (1 strip of 14)

•    28 film-coated tablets (2 strips of 14)

•    56 film-coated tablets (4 strips of 14)

•    20 film-coated tablets (2 strips of 10)

•    50 film-coated tablets (5 strips of 10)

•    100 film-coated tablets (10 strips of 10)

•    30 film-coated tablets (3 strips of 10 or 2 strips of 15)

•    60 film-coated tablets (6 strips of 10 or 4 strips of 15)

•    90 film-coated tablets (9 strips of 10 or 6 strips of 15)

Please note that not all the above pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Accord Healthcare Limited.

Sage house, 319 Pinner road,

North Harrow, HA1 4HF United Kingdom